Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Inventory (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Change in Inventory for 6 consecutive years, with -$5.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 23.81% year-over-year to -$5.4 million, compared with a TTM value of -$3.2 million through Dec 2025, down 132.21%, and an annual FY2025 reading of -$3.2 million, down 132.21% over the prior year.
  • Change in Inventory was -$5.4 million for Q4 2025 at Treace Medical Concepts, down from -$973000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $6.6 million in Q1 2024 and bottomed at -$5.4 million in Q4 2025.
  • Average Change in Inventory over 5 years is $1.4 million, with a median of $2.1 million recorded in 2022.
  • The sharpest move saw Change in Inventory skyrocketed 8745.16% in 2022, then plummeted 6401.49% in 2024.
  • Year by year, Change in Inventory stood at $31000.0 in 2021, then surged by 8745.16% to $2.7 million in 2022, then plummeted by 102.44% to -$67000.0 in 2023, then tumbled by 6401.49% to -$4.4 million in 2024, then dropped by 23.81% to -$5.4 million in 2025.
  • Business Quant data shows Change in Inventory for TMCI at -$5.4 million in Q4 2025, -$973000.0 in Q3 2025, and $4.5 million in Q2 2025.